GSK

NYSE: GSK · Real-Time Price · USD
39.19
0.39 (1.00%)
At close: Aug 15, 2025, 3:42 PM

GSK Income Statement

Financials in GBP. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
31.63B 31.53B 31.38B 31.31B 31.45B 30.74B 30.33B 29.65B 29.33B 29.09B 31.91B 34.06B 35.31B 36.48B 34.11B 33.33B 32.9B 32.43B
Cost of Revenue
9.06B 8.97B 8.97B 8.75B 8.63B 8.48B 8.48B 8.38B 8.54B 8.78B 10.53B 11.97B 12.44B 12.81B 11.6B 11.09B 11.09B 10.98B
Gross Profit
22.57B 22.55B 22.4B 22.56B 22.82B 22.26B 21.84B 21.27B 20.8B 20.3B 21.39B 22.1B 22.88B 23.66B 22.51B 22.23B 21.8B 21.44B
Operating Income
5.12B 5.09B 4.85B 5.21B 6.97B 7.13B 7.22B 8.04B 7.28B 6.22B 6.94B 5.97B 6.71B 7.31B 6.2B 6.37B 6.29B 7.46B
Interest Income
85M 59M 37M 123.98M 115.98M 124.98M 121.98M 112M 110M 98M 76M 54M 36M 22M 25M 26M 22M 16M
Pretax Income
4.62B 4.23B 3.48B 3.3B 5.02B 5.51B 6.07B 7.31B 6.53B 5.44B 6.13B 5.21B 5.95B 6.52B 5.44B 5.56B 5.48B 6.65B
Net Income
3.42B 3.15B 2.58B 2.51B 4.03B 4.48B 4.93B 6.04B 5.35B 4.57B 4.88B 4.17B 4.76B 5.31B 4.58B 4.51B 4.39B 5.26B
Selling & General & Admin
10.67B 10.92B 10.92B 10.87B 9.37B 9.25B 9.32B 9.14B 8.9B 8.7B 9.4B 10.23B 10.82B 11.39B 10.97B 10.88B 10.9B 10.97B
Research & Development
6.98B 6.38B 6.29B 6.31B 6.42B 6.34B 6.22B 5.97B 5.74B 5.64B 5.55B 5.2B 5.35B 5.33B 5.28B 5.3B 4.95B 5.03B
Other Expenses
-200M 166M 335M 167M n/a n/a -477M -1.44B -629M -265M -510M 217M -482M -847M -425M 1.25B 1.23B 2.84B
Operating Expenses
17.45B 17.47B 17.55B 17.35B 15.85B 15.14B 14.62B 13.23B 13.52B 14.08B 14.45B 16.13B 16.16B 16.35B 16.31B 15.87B 15.52B 15.59B
Interest Expense
646M 636M 640M 771.41M 797.41M 808.41M 845.41M 840M 858M 877M 879M 800M 795M 783M 779M 827M 830M 867M
Selling & Marketing Expenses
n/a -75M -92M -157M -157M -82M -65M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
26.51B 26.44B 26.52B 26.1B 24.48B 23.61B 23.1B 21.61B 22.05B 22.86B 24.97B 28.1B 28.6B 29.17B 27.91B 26.96B 26.61B 26.57B
Income Tax Expense
638M 588M 526M 445M 703M 754M 756M 776M 752M 660M 815M 590M 737M 519M 346M 552M 413M 682M
Shares Outstanding (Basic)
2.03B 2.04B 2.04B 2.04B 2.04B 2.03B 2.03B 2.03B 2.03B 2.02B 2.02B 2.02B 2.01B 2.01B 2B 2B 2B 2B
Shares Outstanding (Diluted)
2.06B 2.07B 2.07B 2.07B 2.06B 2.06B 2.06B 2.06B 2.05B 2.04B 2.05B 2.04B 2.03B 2.03B 2.04B 2.03B 2.02B 2.01B
EPS (Basic)
1.70 1.56 1.28 1.24 2.00 2.22 2.44 3.00 2.66 2.28 2.44 2.08 2.28 2.56 2.20 2.16 2.20 2.64
EPS (Diluted)
1.66 1.52 1.24 1.20 1.96 2.20 2.42 2.98 2.64 2.26 2.42 2.04 2.24 2.52 2.18 2.16 2.20 2.62
EBITDA
8.61B 8.24B 7.94B 9.05B 10.43B 10.03B 9.8B 9.47B 10.42B 9.7B 10.65B 10.16B 9.59B 10.17B 8.17B 10.46B 10.63B 11.19B
EBIT
5.27B 4.87B 4.12B 4.01B 5.76B 6.27B 6.86B 8.1B 7.34B 6.27B 6.97B 6.02B 6.76B 7.3B 6.21B 6.33B 6.26B 7.48B
Depreciation & Amortization
3.35B 2.83B 2.55B 3.32B 2.94B 2.76B 2.85B 1.68B 2.06B 2.23B 2.3B 2.8B 2.83B 2.87B 2.52B 4.69B 4.35B 2.52B